List of insiders holdings for Revance Therapeutics Inc.:
- Shares directly owned by the insider.
- Shares indirectly owned by the insider.
- Total shares owned by the insider (sum of shares directly and indirectly owned).
- Total market value if available.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Insider Holder Name | Report Date Time | Shares Owned Directly Indirectly | Total Shares Owned | Filing |
| Eastman Ronald W Director 10% Owner | 2017-05-12 19:47:25 | 9,000 4,134,962 | 4,143,962 | Form 4 |
| NovaQuest Pharma Opportunities Fund III L.P. NQ HCIF General Partner L.P. NQ HCIF GP Ltd. 10% Owner | 2019-02-12 11:36:23 | 1,558,426 0 | 1,558,426 | Form 13G |
| Foley Mark J CEO | 2024-07-02 17:47:39 | 995,935 110,913 | 1,106,848 | Form 4 |
| Rankin Aubrey Director | 2022-03-17 17:50:59 | 94,091 475,913 | 570,004 | Form 4 |
| Hollander David CMO & Global Therapeutics Lead | 2024-02-29 16:32:32 | 278,522 0 | 278,522 | Form 3 |
| Schilke Tobin CFO | 2024-07-02 17:47:03 | 193,666 0 | 193,666 | Form 4 |
| Sjuts Dustin S President | 2024-03-19 18:45:36 | 167,550 0 | 167,550 | Form 4 |
| Browne L Daniel CEO and President | 2019-07-02 21:15:20 | 153,193 409 | 153,602 | Form 4 |
| Moxie Dwight CLO & GC | 2024-03-19 18:44:55 | 137,815 0 | 137,815 | Form 4 |
| Joshi Abhay COO, President of R&D | 2022-03-17 17:56:18 | 120,708 0 | 120,708 | Form 4 |
| Jordan Erica Chief Commercial Officer | 2024-04-17 16:34:50 | 114,864 0 | 114,864 | Form 4 |
| Zavodnick Todd Erik CCO & President, | 2018-10-17 18:53:25 | 96,407 0 | 96,407 | Form 4 |
| Russell Angus C. Director | 2024-05-03 08:47:11 | 74,964 0 | 74,964 | Form 4 |
| Ruegg Curtis EVP, Technical Operations | 2016-06-15 19:29:17 | 72,780 0 | 72,780 | Form 4 |
| Gangolli Julian S Director | 2024-05-03 08:44:31 | 68,564 0 | 68,564 | Form 4 |
| Nolet Chris Director | 2024-05-03 08:46:21 | 67,064 0 | 67,064 | Form 4 |
| Beraud Jill Director | 2024-05-03 08:42:47 | 67,064 0 | 67,064 | Form 4 |
| SILVERNAIL LAUREN P CFO & CBO | 2018-05-24 19:24:06 | 65,497 0 | 65,497 | Form 4 |
| Ware Olivia C Director | 2024-05-03 08:47:58 | 55,133 0 | 55,133 | Form 4 |
| Kolaja Carey OConnor Director | 2024-05-03 08:45:30 | 55,019 0 | 55,019 | Form 4 |
| Coric Vlad Director | 2024-05-03 08:43:48 | 44,242 0 | 44,242 | Form 4 |
| BYRNES ROBERT F Director | 2020-05-15 18:35:49 | 28,500 13,665 | 42,165 | Form 4 |
| Bertolino Arthur Peter EVP and Chief Medical Officer | 2015-11-17 21:45:14 | 34,001 0 | 34,001 | Form 4 |
| GARDNER PHYLLIS Director | 2020-05-15 18:39:52 | 28,500 0 | 28,500 | Form 4 |
| Waugh Jacob Chief Scientific Officer | 2015-05-21 19:08:41 | 28,413 0 | 28,413 | Form 4 |
| McDowell Caryn Gordon SVP, GC & Secretary | 2020-02-19 20:23:23 | 23,453 0 | 23,453 | Form 4 |
| Vickers Philip J. Director | 2022-05-13 18:13:27 | 10,756 0 | 10,756 | Form 4/A |
| ESSEX WOODLANDS HEALTH VENTURES FUND VIII LP ESSEX WOODLANDS HEALTH VENTURES FUND VIII-A LP ESSEX WOODLANDS HEALTH VENTURES FUND VIII-B LP 10% Owner | 2014-04-10 17:45:13 | 0 8,000 | 8,000 | Form 4 |
| Glasheen James Walter Director | 2016-05-09 19:14:14 | 8,000 0 | 8,000 | Form 4 |
| PRYGOCKI MARK A SR Director | 2016-05-09 19:12:25 | 8,000 0 | 8,000 | Form 4 |
| Tunnicliffe Jonathan Director 10% Owner | 2015-05-27 20:33:21 | 8,000 0 | 8,000 | Form 4/A |
| WOOTEN RONALD J Director 10% Owner | 2015-05-27 20:31:37 | 8,000 0 | 8,000 | Form 4/A |
| Allouche Cyril Principal Accounting Officer | 2019-03-19 20:58:46 | 6,400 0 | 6,400 | Form 4 |